Physiotherapy in the Treatment of Breastfeeding Difficulties

Sponsor
Universidad de Almeria (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05843279
Collaborator
(none)
200
2
4

Study Details

Study Description

Brief Summary

The objective of this randomized, single-blind clinical trial is to compare the efficacy of two treatments (Myofunctional Therapy and breastfeeding sessions) in infants who have difficulty breastfeeding during the first week of life.

The main questions to be answered are:
  • Is breastfeeding improved with this type of intervention?

  • What type of intervention is better?

  • After carrying out these interventions, does the baby need to undergo surgery if it presents a sublingual frenulum? Participants must be infants who are one week old and who have been diagnosed with ankyloglossia through the Hazelbaker Scale. They will be randomly distributed into the two intervention groups and after one month of treatment, they will be assessed again using the same scale.

The researchers will compare the results between these two groups in order to verify the best intervention.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Myofunctional therapy
N/A

Detailed Description

Infants who met the inclusion and exclusion criteria, respectively, were accepted to participate in the study. The randomization of the sample was performed by a statistician, who had no prior contact with either the infants or the parents. The online Randomizer (www.randomizer.org) program was used to randomly generate 200 sets of numbers, each containing two numbers ranging from 1 to 2 in random order. After signing the consent, a code was randomly chosen for each patient, thus ensuring that the 200 patients were equally distributed into two groups according to the group number of each code: group 1 (Myofunctional Therapy group) and group 2 (group sessions lactation).

Infants who met the inclusion criteria were referred to the rehabilitation and physiotherapy service. A physical therapist outside the study was in charge of evaluating the measurements of all infants during the first week of life through all the scales detailed below (pre-test). After randomly assigning the infants, another physiotherapist was responsible for applying the intervention once a week for 30 minutes for a period of 30 days. Once the intervention was finished, all the infants (both intervention groups) were reassessed by the physiotherapist outside the study using the same baseline scales (post-test).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Myofunctional Therapy is performed in one group and a breastfeeding session is performed in another group.Myofunctional Therapy is performed in one group and a breastfeeding session is performed in another group.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
A physiotherapist outside the study was in charge of carrying out the first evaluation in the first week of life of the infant. Another physiotherapist was in charge of applying the physiotherapy intervention. After completion of the intervention, all infants were reassessed by another physiotherapist outside the study.
Primary Purpose:
Treatment
Official Title:
Efficacy of a Physiotherapy Treatment in Newborns With Breastfeeding Difficulties
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Myofunctional therapy

The intervention group receives myofunctional therapy sessions in which orofacial exercises are performed.

Procedure: Myofunctional therapy
In one group, physiotherapy intervention is performed on the orofacial structures of the baby and in another group, the posture presented by the mother while breastfeeding her baby is corrected.
Other Names:
  • Breastfeeding session
  • Other: Breastfeeding session

    In this group, a session is held in which the posture and attachment of the baby to the mother's chest is assessed and corrected.

    Procedure: Myofunctional therapy
    In one group, physiotherapy intervention is performed on the orofacial structures of the baby and in another group, the posture presented by the mother while breastfeeding her baby is corrected.
    Other Names:
  • Breastfeeding session
  • Outcome Measures

    Primary Outcome Measures

    1. Hazelbaker scale [one month]

      This scale evaluates the appearance (5 items) and the function of the language (7 items). Each item is scored on a 2/1/0 scale (2 equals good appearance and/or full function; 1 equals moderate appearance and/or partial function; 0 equals no appearance and inadequate function). The maximum appearance score is 10, indicating that there are no limitations in the orofacial structures, and if it is less than 8, a limitation is confirmed. The maximum function score is 14, which reflects preserved function and if it is less than 11, the function is considered to be diminished.

    2. Latch Scale [one month]

      It is made up of different areas of assessment: how the baby latches on, amount of audible swallowing, type/condition of the mother's nipple, mother's comfort level, and amount of help the mother needs to latch on. baby at the breast The rating system is 0/1/2 in each item (0 equals the "least favourable" and 2 the "most favourable"). The highest score is 10, which means that there is no problem in breastfeeding. If the score is less than 9, it means that the mother and baby need help with breastfeeding.

    3. Visual Analogue Scale [one month]

      This scale evaluates the pain suffered by the mother's nipple while the child is breastfeeding. The maximum score is 10 (unbearable pain) and the minimum score is 0 (no pain). Higher scores mean more breastfeeding problems and the need for help from a health professional.

    4. Surgical intervention after treatment [one month]

      If the baby needs frenectomy or frenotomy after the month of treatment

    Secondary Outcome Measures

    1. infant sex [one day]

      if the baby is male or female

    2. mother's age at delivery [one day]

      mother's age when her baby is born

    3. gestational age [one day]

      weeks of gestation of the baby

    4. mother's educational level [one day]

      If the mother has primary or higher education

    5. mother's marital status [one day]

      single or married

    6. type of delivery [one day]

      vaginal delivery or caesarean section

    7. Number of births including the present [one day]

      Number of births including the present

    8. Coryllos and Catherine Watson Genna's type of frenulum classification [one day]

      Type of sublingual frenulum

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Days to 31 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Full-term infants exclusively breastfed

    • Born both by normal delivery and by cesarean section

    • Who presented difficulty in breastfeeding

    Exclusion Criteria:
    • Preterm newborns

    • With low birth weight (less than 2,500 kg)

    • Mothers with flat or inverted nipples

    • Patients who did not wish and did not authorize to participate in the study.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Universidad de Almeria

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Gemma María López Segura, Principal Investigator, Universidad de Almeria
    ClinicalTrials.gov Identifier:
    NCT05843279
    Other Study ID Numbers:
    • 35/2022
    First Posted:
    May 6, 2023
    Last Update Posted:
    May 9, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Gemma María López Segura, Principal Investigator, Universidad de Almeria
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 9, 2023